- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Carisma Therapeutics announced the appointment of Eric Siegel as general counsel and corporate secretary.
With more than 25 years of experience as an attorney in the life sciences industry, Siegel previously served as chief compliance officer at Idorsia Pharmaceuticals US.
He also previously held titles that include executive vice president and general counsel at Incyte Corporation and global chief compliance officer for Jazz Pharmaceuticals.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
The Department of Justice’s Antitrust Division created a new task force to examine collusion and monopolies in the healthcare industry.
The Federal Reserve Board and six large American banks released the results of a pilot climate scenario analysis that explored how resilient the banks’ business models were to climate-related financial risks.
Merrill Lynch was assessed an $825,000 penalty by the Financial Industry Regulatory Authority for alleged supervision failures regarding the execution of marketable equity orders entered into its electronic order systems.
No comments yet